Investing
Nuvau Minerals Inc. to Participate in BMO and PDAC Conferences
Nuvau Minerals Inc. (TSXV: NMC) (‘Nuvau’ or the ‘Company’) is pleased to announce that the Company will be participating in...
Read more
6 Mining and Energy Stocks Make Top 10 on 2025 TSX Venture 50 List
The TSX Venture Exchange has released its annual TSX Venture 50 ranking, recognizing the top-performing companies based on share price...
Read more
West High YieldResources Ltd. Announces Private Placement Offering, Loan Amendments, and World-First Magnesium Battery Breakthrough
West High Yield (W.H.Y.) Resources Ltd. (TSXV: WHY) (‘West High Yield’ or the ‘Company’) is pleased to announce a non-brokered private...
Read more
Exceptional silver and cobalt assays from seaweed
BPH Global (BP8:AU) has announced Exceptional silver and cobalt assays from seaweed Download the PDF here. This post appeared first...
Read more
Gold Price Hits New Record, Breaking US$2,950 for First Time
The gold price reached yet another record high on Thursday (February 20), breaking US$2,950 per ounce. The yellow metal rose...
Read more
Barrick Gold and Mali Reach Settlement, Ending Two Year Mining Dispute
Barrick Gold (TSX:ABX,NYSE:GOLD) has reportedly reached an agreement with the Malian government after nearly two years of issues, resolving a...
Read more
New Purpose ETFs Give Canadian Investors Access to Leading Tech Stocks
Asset management firm Purpose Investments launched seven new yield shares exchange-traded funds (ETFs) on Thursday (February 20), including four that...
Read more
Freegold Achieves Over 93% Recovery Using Albion Process oxidation-CIL Additional Metallurgical Work Remains Ongoing
Total gold recovery of over 93% from a composite comprised of core from 8 drill holes representing the Dolphin/Cleary resource...
Read more
Drills Wide Intervals Within the High Grade Panel and Hits Satellite Zones at Ana Paula, Mexico
HIGHLIGHTS: High Grade Panel 161.0 metres @ 4.26 grams per tonne (g/t) gold including 30.0 metres @ 10.1 g/t gold,...
Read more
Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure
Data demonstrates improvement in cardiac function and reductions in cardiac hypertrophy, remodeling, inflammation, and cell death – key underlying mechanisms...
Read more
